Axid and Requip drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Axid (nizatidine) and Requip (ropinirole hydrochloride). Common drug interactions include anxiety among females and weight decreased among males.
The phase IV clinical study analyzes what interactions people have when they take Axid and Requip. It is created by eHealthMe based on reports of 23 people who take the same drugs from the FDA, and is updated regularly.
What is Axid?
Axid has active ingredients of nizatidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 2,980 Axid users. Check the latest studies of Axid.
What is Requip?
Requip has active ingredients of ropinirole hydrochloride. It is often used in restless leg syndrome. eHealthMe is studying from 22,950 Requip users. Check the latest studies of Requip.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
23 people who take Axid and Requip together, and have interactions are studied.

What are the common drug interactions of Axid and Requip, by gender? *:
female:
- Anxiety
- Fatigue (feeling of tiredness)
- Pain
- Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
- Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
- Decreased appetite
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Lymphoma (cancer that begins in immune system cells)
- Rhinorrhoea (watery mucus discharge from the nose)
- Vomiting
male:
- Weight decreased
- Arthralgia (joint pain)
- Abdominal pain
- Abdominal wound dehiscence (abdominal wound ruptures)
- Acute leukaemia (blood cancer)
- Altered state of consciousness (altered state of mind)
- Anaemia (lack of blood)
- Anxiety
- Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
- Atelectasis (partial or complete collapse of the lung)
What are the common drug interactions of Axid and Requip, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Chronic kidney disease
- Anxiety
- Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
- Renal failure (kidney dysfunction)
- Renal injury (kidney injury)
50-59:
- Foot fracture
- Gastric cancer recurrent (repeat stomach cancer)
- Gastric ulcer (stomach ulcer)
- Gingival pain (gum pain)
- Haemophilus bacteraemia (bacterial infection by haemophilus influenzae)
- Haemorrhoids (a swollen vein or group of veins in the region of the anus)
- Helicobacter test positive
- Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)
- Hypoaesthesia (reduced sense of touch or sensation)
- Hypotension (abnormally low blood pressure)
60+:
- Asthenia (weakness)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Acquired macroglossia (large tongue)
- Acute respiratory failure
- Alopecia (absence of hair from areas of the body)
- Anticonvulsant drug level above therapeutic
- Anxiety
- Aortic valve sclerosis (narrowing of the aortic valve)
- Arrhythmia (irregular heartbeat)
- Atrial hypertrophy (a condition where the left atrium or right atrium of the heart is larger than would be expected)
What are the existing conditions these people have? *
- Quit Smoking: 6 people, 26.09%
- Depression: 5 people, 21.74%
- Pain: 5 people, 21.74%
- Thyroid Diseases: 4 people, 17.39%
- Insomnia (sleeplessness): 4 people, 17.39%
- Asthma: 4 people, 17.39%
- Headache (pain in head): 4 people, 17.39%
- Stress And Anxiety: 4 people, 17.39%
- Arthritis (form of joint disorder that involves inflammation of one or more joints): 4 people, 17.39%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 8.70%
* Approximation only. Some reports may have incomplete information.
Do you take Axid and Requip?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Axid and Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Axid:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Requip:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Axid and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Requip and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on nizatidine and ropinirole hydrochloride (the active ingredients of Axid and Requip, respectively), and Axid and Requip (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lantus cause Flatulence? - 13 seconds ago
- Could Symbicort cause Jaundice - Yellow Skin? - 14 seconds ago
- Drug interactions of Garlic and Estradiol - 16 seconds ago
- Guaifenesin and Renal Disorder for Women aged 50-59 - 29 seconds ago
- Drug interactions of Adcirca and Methotrexate - 34 seconds ago
- Could Furosemide cause Acquired Haemophilia? - 52 seconds ago
- Drug interactions of Atripla and Triamcinolone Acetonide - 59 seconds ago
- Drug interactions of Desyrel and Marine Triglyceride - a minute ago
- Drug interactions of Bricanyl and Effexor - a minute ago
- Drug interactions of Pepcid and Fenofibrate - a minute ago